SCHEMBL19110347

SCHEMBL19110347

CC1(C)c2cc(-c3ccc4sc5cc6cc7sc8ccccc8c7cc6cc5c4c3)ccc2-c2ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)cc21

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PIM3 Q86V86 1/20 0.33
ROCK1 Q13464 1/20 0.33
GPR3 P46089 1/20 0.32
PTPN7 P35236 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN12 Q05209 1/20 0.32
PTPN22 Q9Y2R2 1/20 0.32
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
PTPN1 P18031 1/20 0.31
CYP1A2 P05177 1/20 0.30
ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110352 1.00 ALDH1A1 (0.33) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL17944917 0.94 ESR1 (0.35) PIM3ROCK1PTPN7DUSP3PTPN12
SCHEMBL19110286 0.92 ALDH1A1 (0.34) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL19110285 0.92 ALDH1A1 (0.34) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL24341067 0.91 ALDH1A1 (0.32) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL24341069 0.91 ALDH1A1 (0.32) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL17944006 0.90 ESR1 (0.35)
SCHEMBL19110375 0.89 ALDH1A1 (0.31) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL19110376 0.89 ALDH1A1 (0.31) ALDH1A1MAPTL3MBTL1POLBTDP1
SCHEMBL19110354 0.89 ALOX5 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200905-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALDH1A1 237/4885MAPT 1538/4885L3MBTL1 1565/4885
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALDH1A1 237/4885MAPT 1538/4885L3MBTL1 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.